The Claim

Daily administration of liraglutide at 3 mg for 32 weeks reduces visceral adipose tissue and liver fat content in obese women with polycystic ovary syndrome, leading to improved metabolic health and reduced cardiovascular risk.

Source: Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study.

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
37score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Cause and effect
1 study reviewed
In plain English

In obese women with polycystic ovary syndrome, taking 3 mg of liraglutide daily for 32 weeks reduces fat around internal organs and fat in the liver, which is associated with better metabolic function and lower cardiovascular risk.

See the scientific wording

Liraglutide 3 mg daily for 32 weeks reduces visceral adipose tissue and liver fat content in obese women with polycystic ovary syndrome, contributing to improved metabolic health and reduced cardiovascular risk.

Why this might work

Liraglutide activates receptors in the brain and pancreas that reduce hunger and improve insulin release, which lowers insulin levels in the blood. Lower insulin reduces fat storage in the abdomen and liver, while also decreasing the production of male hormones that worsen fat buildup. This allows the liver to burn more fat and store less, while fat tissue becomes less inflamed, improving overall metabolism and reducing heart disease risk.

Verified mechanismbased on 1 study

What the research says

1 study

  1. Study: Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study.

    This study found that obese women with PCOS who took liraglutide lost more weight and had better hormone and blood sugar levels than those who didn’t — and it says this happened even beyond just losing weight, meaning they likely lost dangerous fat around their organs and liver too, which lowers heart and diabetes risk.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.